Catherine G. Zimmermann-Ivol
Geneva College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Catherine G. Zimmermann-Ivol.
BMC Genomics | 2006
Alexander Scherl; Patrice Francois; Yvan Charbonnier; Jacques Deshusses; Thibaud Koessler; Antoine Huyghe; Manuela Bento; Jianru Stahl-Zeng; Adrien Fischer; Alexandre Masselot; Alireza Vaezzadeh; Francesca Gallé; Adriana Maria Renzoni; Pierre Vaudaux; Daniel Lew; Catherine G. Zimmermann-Ivol; Pierre-Alain Binz; Jean-Charles Sanchez; Denis F. Hochstrasser; Jacques Schrenzel
BackgroundTo unravel molecular targets involved in glycopeptide resistance, three isogenic strains of Staphylococcus aureus with different susceptibility levels to vancomycin or teicoplanin were subjected to whole-genome microarray-based transcription and quantitative proteomic profiling. Quantitative proteomics performed on membrane extracts showed exquisite inter-experimental reproducibility permitting the identification and relative quantification of >30% of the predicted S. aureus proteome.ResultsIn the absence of antibiotic selection pressure, comparison of stable resistant and susceptible strains revealed 94 differentially expressed genes and 178 proteins. As expected, only partial correlation was obtained between transcriptomic and proteomic results during stationary-phase. Application of massively parallel methods identified one third of the complete proteome, a majority of which was only predicted based on genome sequencing, but never identified to date. Several over-expressed genes represent previously reported targets, while series of genes and proteins possibly involved in the glycopeptide resistance mechanism were discovered here, including regulators, global regulator attenuator, hyper-mutability factor or hypothetical proteins. Gene expression of these markers was confirmed in a collection of genetically unrelated strains showing altered susceptibility to glycopeptides.ConclusionOur proteome and transcriptome analyses have been performed during stationary-phase of growth on isogenic strains showing susceptibility or intermediate level of resistance against glycopeptides. Altered susceptibility had emerged spontaneously after infection with a sensitive parental strain, thus not selected in vitro. This combined analysis allows the identification of hundreds of proteins considered, so far as hypothetical protein. In addition, this study provides not only a global picture of transcription and expression adaptations during a complex antibiotic resistance mechanism but also unravels potential drug targets or markers that are constitutively expressed by resistant strains regardless of their genetic background, amenable to be used as diagnostic targets.
Journal of Microbiological Methods | 2010
Ali R. Vaezzadeh; Jacques M. P. Deshusses; Patrice Waridel; Patrice Francois; Catherine G. Zimmermann-Ivol; Pierre Lescuyer; Jacques Schrenzel; Denis F. Hochstrasser
In bottom-up proteomics, rapid and efficient protein digestion is crucial for data reliability. However, sample preparation remains one of the rate-limiting steps in proteomics workflows. In this study, we compared the conventional trypsin digestion procedure with two accelerated digestion protocols based on shorter reaction times and microwave-assisted digestion for the preparation of membrane-enriched protein fractions of the human pathogenic bacterium Staphylococcus aureus. Produced peptides were analyzed by Shotgun IPG-IEF, a methodology relying on separation of peptides by IPG-IEF before the conventional LC-MS/MS steps of shotgun proteomics. Data obtained on two LC-MS/MS platforms showed that accelerated digestion protocols, especially the one relying on microwave irradiation, enhanced the cleavage specificity of trypsin and thus improved the digestion efficiency especially for hydrophobic and membrane proteins. The combination of high-throughput proteomics with accelerated and efficient sample preparation should enhance the practicability of proteomics by reducing the time from sample collection to obtaining the results.
Rapid Communications in Mass Spectrometry | 2008
Ali R. Vaezzadeh; Jovan Simicevic; Alexis Chauvet; Patrice Francois; Catherine G. Zimmermann-Ivol; Pierre Lescuyer; Jacques P. M. Deshusses; Denis F. Hochstrasser
Imaging Mass Spectrometry (IMS) has emerged as a powerful technique in the field of proteomics. The use of Immobilized pH Gradient-IsoElectric Focusing (IPG-IEF) is also a new trend, as the first dimension of separation, in shotgun proteomics. We report a combination of these two outstanding technologies. This approach is based on the separation of shotgun-produced peptides by IPG-IEF. The peptides are then transferred by capillarity to a capture membrane, which is then scanned by the mass spectrometer to generate MS images. This high-throughput methodology allows a preview of the sample to be obtained in a single day. We report the application of this new pipeline for differential comparison of the membrane proteome of two different strains of Staphylococcus aureus bacteria in a proof-of-principle experiment.
Proteomics Clinical Applications | 2008
Pierre Lescuyer; Agnès Pernin; Alexandre Hainard; Caty Bigeire; Jennifer A. Burgess; Catherine G. Zimmermann-Ivol; Jean-Charles Sanchez; Jürg A. Schifferli; Denis F. Hochstrasser; Solange Moll
Podocytes (glomerular visceral epithelial cells) release vesicles into urine. Podocyte vesicle‐enriched fractions from normal and pathological human urine samples were prepared for proteomic analysis. An immunoadsorption method was applied and enrichment of podocyte vesicles was assessed. We identified 76 unique proteins. One protein, serum paraoxonase/arylesterase 1 (PON‐1), was newly identified in normal human urine sample. We confirmed this result and showed PON‐1 expression in normal human kidney. These results demonstrated the potential for using the urine samples enriched in podocyte vesicles as a starting material in studies aimed at discovery of biomarkers for diseases.
Proteomics | 2005
Patricia M. Palagi; Daniel Walther; Manfredo Quadroni; Sébastien Catherinet; Jennifer A. Burgess; Catherine G. Zimmermann-Ivol; Jean-Charles Sanchez; Pierre-Alain Binz; Denis F. Hochstrasser; Ron D. Appel
Molecular & Cellular Proteomics | 2004
Catherine G. Zimmermann-Ivol; Pierre Burkhard; Josette Le Floch-Rohr; Laure Allard; Denis F. Hochstrasser; Jean-Charles Sanchez
Proteomics | 2004
Pierre Lescuyer; Laure Allard; Catherine G. Zimmermann-Ivol; Jennifer A. Burgess; Séverine Hughes-Frutiger; Pierre Burkhard; Jean-Charles Sanchez; Denis F. Hochstrasser
Journal of Microbiological Methods | 2005
Alexander Scherl; Patrice Francois; Manuela Bento; Jacques Deshusses; Yvan Charbonnier; Véronique Converset; Antoine Huyghe; Nadia Walter; Christine Hoogland; Ron D. Appel; Jean-Charles Sanchez; Catherine G. Zimmermann-Ivol; Garry L. Corthals; Denis F. Hochstrasser; Jacques Schrenzel
Rapid Communications in Mass Spectrometry | 2005
Alexander Scherl; Catherine G. Zimmermann-Ivol; Joel Di Dio; Ali R. Vaezzadeh; Pierre-Alain Binz; Michel Amez-Droz; Roland Cochard; Jean-Charles Sanchez; Matthias Glückmann; Denis F. Hochstrasser
Rapid Communications in Mass Spectrometry | 2006
Stefan L. Luxembourg; Ali R. Vaezaddeh; Erika R. Amstalden; Catherine G. Zimmermann-Ivol; Denis F. Hochstrasser; Ron M. A. Heeren